TY - JOUR
T1 - Home visits as part of a new care pathway (iAID) to improve quality of care and quality of life in ostomy patients: a cluster-randomized stepped-wedge trial
AU - Sier, M. F.
AU - Oostenbroek, R. J.
AU - Dijkgraaf, M. G. W.
AU - Veldink, G. J.
AU - Bemelman, W. A.
AU - Pronk, A.
AU - Spillenaar-Bilgen, E. J.
AU - Kelder, W.
AU - Hoff, C.
AU - Ubbink, D. T.
AU - AUTHOR GROUP
AU - Havenga, K.
AU - Veltkamp, S. C.
AU - T Dekker, J. W.
AU - Boerma, D.
AU - Eijsbouts, Q. A. J.
AU - Lamme, B.
AU - Vuylsteke, R. J. C. L. M.
AU - Tobon Morales, R. E.
AU - van Tets, W. F.
PY - 2017
Y1 - 2017
N2 - Aim Morbidity in patients with an ostomy is high. A new care pathway, including perioperative home visits by enterostomal therapists, was studied to assess whether more elaborate education and closer guidance could reduce stoma-related complications and improve quality of life (QoL), at acceptable cost. Method Patients requiring an ileostomy or colostomy, for any inflammatory or malignant bowel disease, were included in a 15-centre cluster-randomized 'steppedwedge' study. Primary outcomes were stoma-related complications and QoL, measured using the Stoma-QOL, 3 months after surgery. Secondary outcomes included costs of care. Results The standard pathway (SP) was followed by 113 patients and the new pathway (NP) by 105 patients. Although the overall number of stoma-related complications was similar in both groups (SP 156, NP 150), the proportion of patients experiencing one or more stoma-related complications was significantly higher in the NP (72% vs 84%, risk difference 12%; 95% CI: 0.3 - 23.3%). Although in the NP more patients had stoma-related complications, QoL scores were significantly better (P <0.001). In the SP more patients required extra care at home for their ostomy than in the NP (60.6% vs 33.7%, respectively; risk difference 26.9%, 95% CI: 13.5-40.4%). Stoma revision was done more often in the SP (n = 11) than in the NP (n = 2). Total costs in the SP did not differ significantly from the NP. Conclusion The NP did not reduce the number of stoma-related complications but did lead to improved quality of care and life, against similar costs. Based on these results the NP, including perioperative home visits by an enterostomal therapist, can be recommended
AB - Aim Morbidity in patients with an ostomy is high. A new care pathway, including perioperative home visits by enterostomal therapists, was studied to assess whether more elaborate education and closer guidance could reduce stoma-related complications and improve quality of life (QoL), at acceptable cost. Method Patients requiring an ileostomy or colostomy, for any inflammatory or malignant bowel disease, were included in a 15-centre cluster-randomized 'steppedwedge' study. Primary outcomes were stoma-related complications and QoL, measured using the Stoma-QOL, 3 months after surgery. Secondary outcomes included costs of care. Results The standard pathway (SP) was followed by 113 patients and the new pathway (NP) by 105 patients. Although the overall number of stoma-related complications was similar in both groups (SP 156, NP 150), the proportion of patients experiencing one or more stoma-related complications was significantly higher in the NP (72% vs 84%, risk difference 12%; 95% CI: 0.3 - 23.3%). Although in the NP more patients had stoma-related complications, QoL scores were significantly better (P <0.001). In the SP more patients required extra care at home for their ostomy than in the NP (60.6% vs 33.7%, respectively; risk difference 26.9%, 95% CI: 13.5-40.4%). Stoma revision was done more often in the SP (n = 11) than in the NP (n = 2). Total costs in the SP did not differ significantly from the NP. Conclusion The NP did not reduce the number of stoma-related complications but did lead to improved quality of care and life, against similar costs. Based on these results the NP, including perioperative home visits by an enterostomal therapist, can be recommended
U2 - https://doi.org/10.1111/codi.13630
DO - https://doi.org/10.1111/codi.13630
M3 - Article*
C2 - 28192627
VL - 19
SP - 739
EP - 749
JO - Colorectal Disease
JF - Colorectal Disease
SN - 1462-8910
IS - 8
ER -